Bio-Techne William Blair Initiates Coverage of Bio-Techne With Outperform Rating The investment bank emphasized Bio-Techne's position in multiple high-growth and attractive end markets, including cell and gene therapy, spatial biology, and liquid biopsy. Top Five Articles on GenomeWeb Last Week: Agilent, Bruker, Foundation Medicine, More Last week, GenomeWeb's readers were most interested in Agilent Technologies announcing that it is discontinuing its Resolution Bioscience business. Sylvester Comprehensive Cancer Center Wins $2.5M NCI Grant to Develop Prostate Cancer Test The team will work with collaborators at Bio-Techne's Exosome Diagnostics to develop its prostate cancer biomarker on a new platform. Bio-Techne, Akoya End Partnership to Develop Automated Spatial Biology Workflow The companies announced in 2022 that they would work to enable automated workflows for RNAscope tests on Akoya's spatial phenotyping systems. 'COVID Hangover' Subsiding, But China Uncertainty Remains for Bio-Techne Premium The company said on Tuesday that its fiscal fourth quarter revenues rose 5 percent and full-year 2023 revenues climbed 3 percent. Jul 14, 2023 In Brief This Week: DermTech, T2 Biosystems, Cofactor Genomics, Bio-Techne, Lunaphore, More Jun 22, 2023 Bio-Techne to Acquire Swiss Spatial Biology Firm Lunaphore Jun 5, 2023 Recent Data Boosts Clinical Utility Case for Exosome Diagnostics Prostate Cancer Test Premium May 19, 2023 New Products Posted to GenomeWeb: BD, Bio-Techne, PhenomeX, Deepcell, Ozette, Telesis Bio, More May 12, 2023 New Products Posted to GenomeWeb: Bio-Techne, Grifols, Genome Insight, Genialis, Lucence May 3, 2023 Bio-Techne Fiscal Q3 Revenues Tick Up 1 Percent as Firm Faces Macroeconomic Headwinds Apr 17, 2023 Bio-Techne, Lunaphore Partner on Spatial Workflow Combining Protein and RNA Measurements Apr 6, 2023 In Brief This Week: HTG Molecular Diagnostics, Indivumed, Bio-Techne, Shuwen Biotech, More Mar 3, 2023 In Brief This Week: DermTech, Applied BioCode, Devyser, DiaSorin, Cytek, Bio-Techne, GenScript, More Feb 24, 2023 National Government Services Expands Coverage for Bio-Techne's ExoDx Prostate Cancer Test Jan 13, 2023 New Products Posted to GenomeWeb: Twist Bioscience, Centogene, Juno Diagnostics, Bio-Techne, More Jan 12, 2023 JP Morgan Healthcare Conference, Day 3: Invitae, NanoString, Bio-Rad, Olink, More Dec 21, 2022 Genomics Firms Tackle Carbon Emissions, Face Obstacles to Net-Zero Goals From Suppliers, Shipping Premium Dec 1, 2022 Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay Nov 18, 2022 In Brief This Week: 908 Devices, Natera, PerkinElmer, Hologic, Hamilton, BioFluidiX, More Nov 1, 2022 Bio-Techne Fiscal Q1 Revenues Rise 5 Percent Sep 26, 2022 Bio-Techne Files UK Patent Infringement Suit Against Molecular Instruments Sep 9, 2022 In Brief This Week: Prenetics, MGI Tech, Strata Oncology, Mainz Biomed, Bio-Techne, More Aug 19, 2022 New Products Posted to GenomeWeb: Qiagen, Boston Heart Diagnostics, Bio-Techne, More Aug 4, 2022 Bio-Techne Hints at Future M&A Plans Premium Load More Breaking News Genetic Contributors to Plasma Protein Levels Unearthed in Multiple Studies Standard BioTools, SomaLogic to Merge Arima Genomics, Protean BioDiagnostics Launch 3D Genomics Cancer Testing Joint Venture Pathnostics UTI Test Nabs New York State Approval NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.